JPS59152399A - 核酸誘導体の製造方法 - Google Patents
核酸誘導体の製造方法Info
- Publication number
- JPS59152399A JPS59152399A JP2575783A JP2575783A JPS59152399A JP S59152399 A JPS59152399 A JP S59152399A JP 2575783 A JP2575783 A JP 2575783A JP 2575783 A JP2575783 A JP 2575783A JP S59152399 A JPS59152399 A JP S59152399A
- Authority
- JP
- Japan
- Prior art keywords
- nucleoside
- silicon compound
- base
- carboxylic acid
- organic carboxylic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000007523 nucleic acids Chemical class 0.000 title abstract description 6
- 102000039446 nucleic acids Human genes 0.000 title abstract description 6
- 108020004707 nucleic acids Proteins 0.000 title abstract description 6
- 239000002777 nucleoside Substances 0.000 claims abstract description 19
- 150000003833 nucleoside derivatives Chemical class 0.000 claims abstract description 18
- -1 carboxylic acid halide Chemical class 0.000 claims abstract description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims abstract description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 8
- 150000003377 silicon compounds Chemical class 0.000 claims abstract description 8
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 claims abstract description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 3
- 125000005843 halogen group Chemical group 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000003835 nucleoside group Chemical group 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 8
- 239000000047 product Substances 0.000 abstract description 5
- MXMOTZIXVICDSD-UHFFFAOYSA-N anisoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1 MXMOTZIXVICDSD-UHFFFAOYSA-N 0.000 abstract description 4
- 230000001588 bifunctional effect Effects 0.000 abstract description 4
- 238000010353 genetic engineering Methods 0.000 abstract description 3
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 abstract 1
- 229940073608 benzyl chloride Drugs 0.000 abstract 1
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- LIKFHECYJZWXFJ-UHFFFAOYSA-N dimethyldichlorosilane Chemical compound C[Si](C)(Cl)Cl LIKFHECYJZWXFJ-UHFFFAOYSA-N 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- PIXHJAPVPCVZSV-YNEHKIRRSA-N n-[9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]benzamide Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(NC(=O)C=3C=CC=CC=3)=C2N=C1 PIXHJAPVPCVZSV-YNEHKIRRSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- SKDHHIUENRGTHK-UHFFFAOYSA-N 4-nitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC=C(C(Cl)=O)C=C1 SKDHHIUENRGTHK-UHFFFAOYSA-N 0.000 description 1
- IHLOTZVBEUFDMD-UUOKFMHZSA-N 7-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,2-dioxo-1h-imidazo[4,5-c][1,2,6]thiadiazin-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(NS(=O)(=O)NC2=O)=C2N=C1 IHLOTZVBEUFDMD-UUOKFMHZSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- LTKCXZGFJFAPLY-OERIEOFYSA-N [1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]azanium;chloride Chemical compound Cl.O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 LTKCXZGFJFAPLY-OERIEOFYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 125000004122 cyclic group Chemical class 0.000 description 1
- OSXYHAQZDCICNX-UHFFFAOYSA-N dichloro(diphenyl)silane Chemical compound C=1C=CC=CC=1[Si](Cl)(Cl)C1=CC=CC=C1 OSXYHAQZDCICNX-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- RMZSTOAGUSEJFY-UHFFFAOYSA-N methyl-[methyl(phenyl)silyl]oxy-phenylsilane Chemical compound C=1C=CC=CC=1[SiH](C)O[SiH](C)C1=CC=CC=C1 RMZSTOAGUSEJFY-UHFFFAOYSA-N 0.000 description 1
- YHVXBEVXKRIKOC-YNEHKIRRSA-N n-[9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]-4-nitrobenzamide Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(NC(=O)C=3C=CC(=CC=3)[N+]([O-])=O)=C2N=C1 YHVXBEVXKRIKOC-YNEHKIRRSA-N 0.000 description 1
- WLTBUTVYURQDEF-IPMKNSEASA-N n-benzoyl-n-[9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]benzamide Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(N(C(=O)C=3C=CC=CC=3)C(=O)C=3C=CC=CC=3)=C2N=C1 WLTBUTVYURQDEF-IPMKNSEASA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- OENLEHTYJXMVBG-UHFFFAOYSA-N pyridine;hydrate Chemical compound [OH-].C1=CC=[NH+]C=C1 OENLEHTYJXMVBG-UHFFFAOYSA-N 0.000 description 1
- 238000005475 siliconizing Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000005051 trimethylchlorosilane Substances 0.000 description 1
Landscapes
- Saccharide Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2575783A JPS59152399A (ja) | 1983-02-17 | 1983-02-17 | 核酸誘導体の製造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2575783A JPS59152399A (ja) | 1983-02-17 | 1983-02-17 | 核酸誘導体の製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59152399A true JPS59152399A (ja) | 1984-08-31 |
| JPS637557B2 JPS637557B2 (enrdf_load_stackoverflow) | 1988-02-17 |
Family
ID=12174702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2575783A Granted JPS59152399A (ja) | 1983-02-17 | 1983-02-17 | 核酸誘導体の製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59152399A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007019221A3 (en) * | 2005-08-03 | 2007-06-28 | Rnd Pharmaceuticals Inc | Pharmaceutical compositions of silicon-containing substituted adenosine nucleoside amide analogs |
-
1983
- 1983-02-17 JP JP2575783A patent/JPS59152399A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007019221A3 (en) * | 2005-08-03 | 2007-06-28 | Rnd Pharmaceuticals Inc | Pharmaceutical compositions of silicon-containing substituted adenosine nucleoside amide analogs |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS637557B2 (enrdf_load_stackoverflow) | 1988-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210269470A1 (en) | Segment for use in synthesis of oligonucleotide, method for producing the same, and method for synthesizing oligonucleotide using the same | |
| JP3653292B2 (ja) | ５−メチルウリジンを用いる２’，３’−ジデヒドロ−３’−デオキシチミジン（ｄ４Ｔ）の大量製造法 | |
| JP3677790B2 (ja) | ヌクレオシド誘導体とその製造方法 | |
| TW467915B (en) | Process for the preparation of cefodizime | |
| JPH0959292A (ja) | ４−アミノピリミジンヌクレオシドの製造法 | |
| JPS59152399A (ja) | 核酸誘導体の製造方法 | |
| JPWO2017221929A1 (ja) | リボ核酸ｈ−ホスホネートモノマーの合成方法および本モノマーを用いたオリゴヌクレオチド合成 | |
| JPH0291088A (ja) | ホスファイトおよびヌクレオシド‐３’‐ホスファイト誘導体およびこれを用いるオリゴヌクレオチドの合成法 | |
| JPS61263995A (ja) | シトシンヌクレオシド類の製造法 | |
| JPS5936914B2 (ja) | セフアロスポリン類縁体 | |
| JPH06135988A (ja) | ヌクレオシド誘導体 | |
| JPH04253993A (ja) | デオキシヌクレオシド類の製造方法 | |
| WO2001079248A1 (fr) | Procede de preparation de derives de cytidine | |
| JPS6230998B2 (enrdf_load_stackoverflow) | ||
| JPH06107641A (ja) | １−（２−カルボキシフェニル）インダゾール誘導体の製造方法 | |
| JP4294747B2 (ja) | ヒドロキシピペリジン誘導体及びその製造方法 | |
| WO2006095740A1 (ja) | 置換カルバモイル基を保護基とした核酸の合成方法 | |
| JP2003261559A (ja) | エスクレチンの製法 | |
| JPH0569839B2 (enrdf_load_stackoverflow) | ||
| JP2001354692A (ja) | シチジン誘導体の製造法 | |
| JPH06135989A (ja) | ヌクレオシド誘導体 | |
| JPH06135962A (ja) | ２’，３’−ジデオキシヌクレオシド誘導体の製造方法 | |
| GB2096596A (en) | 8-quinolinesulfonyl derivatives and their synthesis and use as coupling agents in nucleotide chemistry | |
| JPS62175492A (ja) | Ｎ−ホスフイノチオイルアミン誘導体の製造方法 | |
| JPH07252293A (ja) | デオキシリボヌクレオシド誘導体およびその製造方法 |